Lv72
4950 积分 2021-07-15 加入
Golidocitinib and chidamide for refractory or relapsed peripheral T-cell lymphoma: A preliminary cost-effectiveness analysis in China
11秒前
待确认
Dual epigenetic therapy plus chemotherapy in peripheral T cell lymphoma with T follicular helper phenotype
2分钟前
已完结
Peripheral T-cell lymphoma: Are all patients high-risk?
1小时前
已完结
The role of PET/CT in peripheral T‐cell lymphoma: Results from the PET/CT substudy of the UK NCRI phase 2 CHEMO‐T trial
1小时前
已完结
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial
1小时前
已完结
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study
19小时前
已完结
Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B‐Cell Lymphoma: A Real‐World, Multi‐Center, Retrospective Cohort Study
4天前
已完结
Transcript profiling and gene regulation of the human pre-implantation embryo: parental effects and impact of ARTs
1个月前
已完结
Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial
1个月前
已完结
Isatuximab Subcutaneous by On-Body Delivery System vs Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase 3 IRAKLIA Study
1个月前
已关闭
皖公网安备34019202002308
